Skip to main content
. 2021 Apr 6;9:659783. doi: 10.3389/fcell.2021.659783

FIGURE 4.

FIGURE 4

Evaluation of visual function in EXOPACAP38-treated rats after ONC. (A) F-VEP was recorded at 7 days after injury in normal controls; untreated group; and EXO-, PACAP38-, and EXOPACAP38-treated groups. (B) Analysis of N2P2 wave at 7 days after injury (n = 4; values are mean ± SEM, one-way ANOVA, *P < 0.05). (C) Analysis of P2-wave latencies at 7 days after injury. No statistical significance in P2-wave amplitudes was observed at 7 days after injury in the EXOPACAP38-treated group compared with the untreated group (n = 4; values are mean ± SEM, one-way ANOVA, *P < 0.05). (D) F-VEP was recorded at 14 days after injury in normal controls; untreated group; and EXO-, PACAP38-, and EXOPACAP38-treated groups. (E) Analysis of N2P2 wave at 14 days after injury (n = 4; values are mean ± SEM, one-way ANOVA, **P < 0.01). (F) Analysis of P2-wave latencies at 14 days after injury. Significant improvement in P2-wave latencies was achieved at 14 days after injury in the EXOPACAP38-treated group compared with the untreated group (n = 4; values are mean ± SEM, one-way ANOVA, *P < 0.05).